Download PDF
Thromb Haemost 1997; 78(02): 959
DOI: 10.1055/s-0038-1657660
Letter to the Editor
Schattauer GmbH Stuttgart

Rapid Elimination of a High-titered F VIII Inhibitor by High Dose Recombinant F VIII Combined with High Dose Immunoglobulin Infusion

Christine Mauz-Körholz
Klinik für Pädiatrische Hämatologie und Onkologie, Med. Einrichtungen, Kinderklinik, Heinrich-Heine-Universität, Düsseldorf, Germany
,
Dieter Körholz
Klinik für Pädiatrische Hämatologie und Onkologie, Med. Einrichtungen, Kinderklinik, Heinrich-Heine-Universität, Düsseldorf, Germany
,
Ulrich Göbel
Klinik für Pädiatrische Hämatologie und Onkologie, Med. Einrichtungen, Kinderklinik, Heinrich-Heine-Universität, Düsseldorf, Germany
› Author Affiliations
Further Information

Publication History

Received 28 1997

Accepted after revision 15 April 1997

Publication Date:
30 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Brackmann HH. Induced immune tolerance in F VIII inhibitor patients. Progr Clin Biol Res 1986; 150: 181-195
    PubMedGoogle Scholar
  • 2 Nilsson IM, Bemtorp E, Zettervalll O. Induction of immune tolerance inpatients with hemophilia and antibodies to F VIII by combined treatment with intravenous IgG, cyclophosphamide and factor VIII. N Engl J Med 1988; 328: 947-950
    PubMedGoogle Scholar
  • 3 Kreuz W, Becker S, Linz E. et al Factor VIII inhibitors in patients with hemophilia. A epidemiology of inhibitor development and induction of immune tolerance for factor VIII. Sem Thromb Haemost 1995; 21: 382-389
    Article in Thieme ConnectPubMedGoogle Scholar